Whole-Blood Gene Expression in Pulmonary Nontuberculous Mycobacterial Infection
- PMID: 29206475
- PMCID: PMC5894497
- DOI: 10.1165/rcmb.2017-0230OC
Whole-Blood Gene Expression in Pulmonary Nontuberculous Mycobacterial Infection
Abstract
The factors predisposing toward the development of pulmonary nontuberculous mycobacterial (pNTM) disease and influencing disease progression remain unclear. Impaired immune responses have been reported in individuals with pNTM disease, but data are limited and inconsistent. In this study, we sought to use gene expression profiling to examine the host response to pNTM disease. Microarray analysis of whole-blood gene expression was performed on 25 subjects with pNTM disease and 27 uninfected control subjects with respiratory disease. Gene expression results were compared with phenotypic variables and survival data. Compared with uninfected control subjects, pNTM disease was associated with downregulation of 213 transcripts enriched for terms related to T cell signaling, including IFNG. Reduced IFNG expression was associated with more severe computed tomography changes and impaired lung function. Mortality was associated with the expression of transcripts related to the innate immune response and inflammation, whereas transcripts related to T and B cell function were associated with improved survival. These findings suggest that pNTM disease is associated with an aberrant immune response, which may reflect an underlying propensity to infection or result from NTM infection itself. There were important differences in the immune response associated with survival and mortality in pNTM disease.
Keywords: gene expression profiling; interferon-γ; nontuberculous mycobacteria.
Figures


Comment in
-
Reply to: Reduced IFN-γ in Patients with Pulmonary Nontuberculous Mycobacterial Disease: Potentially Multiple Causes.Am J Respir Cell Mol Biol. 2018 Jul;59(1):131. doi: 10.1165/rcmb.2018-0032LE. Am J Respir Cell Mol Biol. 2018. PMID: 29957047 No abstract available.
-
Reduced IFN-γ in Patients with Pulmonary Nontuberculous Mycobacterial Disease: Potentially Multiple Causes.Am J Respir Cell Mol Biol. 2018 Jul;59(1):130-131. doi: 10.1165/rcmb.2018-0012LE. Am J Respir Cell Mol Biol. 2018. PMID: 29957052 No abstract available.
Similar articles
-
Patients with nontuberculous mycobacterial lung disease exhibit unique body and immune phenotypes.Am J Respir Crit Care Med. 2013 Jan 15;187(2):197-205. doi: 10.1164/rccm.201206-1035OC. Epub 2012 Nov 9. Am J Respir Crit Care Med. 2013. PMID: 23144328 Free PMC article.
-
Pulmonary Nontuberculous Mycobacterial Infection. A Multisystem, Multigenic Disease.Am J Respir Crit Care Med. 2015 Sep 1;192(5):618-28. doi: 10.1164/rccm.201502-0387OC. Am J Respir Crit Care Med. 2015. PMID: 26038974 Free PMC article.
-
Pulmonary non-tuberculous mycobacterial infections: current state and future management.Eur J Clin Microbiol Infect Dis. 2020 May;39(5):799-826. doi: 10.1007/s10096-019-03771-0. Epub 2019 Dec 18. Eur J Clin Microbiol Infect Dis. 2020. PMID: 31853742 Free PMC article. Review.
-
Cough physiology in elderly women with nontuberculous mycobacterial lung infections.J Appl Physiol (1985). 2017 May 1;122(5):1262-1266. doi: 10.1152/japplphysiol.00939.2016. Epub 2017 Mar 2. J Appl Physiol (1985). 2017. PMID: 28255087
-
The genetics of nontuberculous mycobacterial infection.Expert Rev Mol Med. 2003 Feb 28;5(6):1-13. doi: 10.1017/S1462399403005908. Expert Rev Mol Med. 2003. PMID: 14987409 Review.
Cited by
-
Functional associations of pleuroparenchymal fibroelastosis and emphysema with hypersensitivity pneumonitis.Respir Med. 2018 May;138:95-101. doi: 10.1016/j.rmed.2018.03.031. Epub 2018 Mar 30. Respir Med. 2018. PMID: 29724400 Free PMC article.
-
Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact.Eur Respir J. 2020 Jul 9;56(1):1902135. doi: 10.1183/13993003.02135-2019. Print 2020 Jul. Eur Respir J. 2020. PMID: 32299855 Free PMC article.
-
Whole blood RNA-seq demonstrates an increased host immune response in individuals with cystic fibrosis who develop nontuberculous mycobacterial pulmonary disease.PLoS One. 2022 Dec 8;17(12):e0278296. doi: 10.1371/journal.pone.0278296. eCollection 2022. PLoS One. 2022. PMID: 36480571 Free PMC article.
-
Characterizing and correcting immune dysfunction in non-tuberculous mycobacterial disease.Front Immunol. 2022 Nov 10;13:1047781. doi: 10.3389/fimmu.2022.1047781. eCollection 2022. Front Immunol. 2022. PMID: 36439147 Free PMC article.
-
Antigen-specific cytokine profiles for pulmonary Mycobacterium avium complex disease stage diagnosis.Front Immunol. 2023 Jul 14;14:1222428. doi: 10.3389/fimmu.2023.1222428. eCollection 2023. Front Immunol. 2023. PMID: 37520555 Free PMC article.
References
-
- Hayashi M, Takayanagi N, Kanauchi T, Miyahara Y, Yanagisawa T, Sugita Y. Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2012;185:575–583. - PubMed
-
- Andréjak C, Thomsen VØ, Johansen IS, Riis A, Benfield TL, Duhaut P, et al. Nontuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factors. Am J Respir Crit Care Med. 2010;181:514–521. - PubMed
-
- Gommans EPAT, Even P, Linssen CFM, van Dessel H, van Haren E, de Vries GJ, et al. Risk factors for mortality in patients with pulmonary infections with non-tuberculous mycobacteria: a retrospective cohort study. Respir Med. 2015;109:137–145. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases